for the normal cell cycle-dependent activation of numerthe E2F2 Ϫ/Ϫ genotype ( Figure 1C ) appeared at a frequency close to the expected Mendelian frequency: 97 ous E2F-responsive genes of both primary and tumor were ϩ/ϩ, 172 were ϩ/Ϫ and 82 were Ϫ/Ϫ ( 2 ϭ 1.42 ϽϽ cells. E2F3-deficient mice demonstrate that E2F3 is par-5.99, p ϭ 0.05), indicating that all genotypes were equally ticularly crucial for normal fibroblast proliferation and viable. The E2F2 Ϫ/Ϫ mice survived to adulthood, were results in an embryonic lethal phenotype (Humbert et fertile, and produced normal offspring. We confirmed al., 2000). Mutation of E2F1 reveals that it normally funcby Northern analysis that the targeted mutation in the tions as a promoter of apoptosis, particularly in devel-E2F2 gene abolishes its expression in these animals oping thymocytes, and as a tumor suppressor possibly ( Figure 1D ). via its role as a promoter of apoptosis (Field et al., 1996; Yamasaki et al., 1996 Yamasaki et al., , 1998 .
Aged E2F2-Deficient Mice Die The third member of this E2F subgroup, E2F2, was of Systemic Autoimmune Disease originally identified by low-stringency hybridization as Both the gross and microscopic morphology of organs an E2F1-related gene, together with E2F3 (Kaelin et al., from 4-to 8-week-old E2F2 Ϫ/Ϫ mice were normal (data 1992; Ivey-Hoyle et al., 1993), and it shows high senot shown). However, by 15 months of age 67% of the quence homology with E2F1 and E2F3. Similar to E2F1
wild-type animals were alive and apparently healthy, and E2F3, ectopic expression of E2F2 promotes S phase whereas only 27% of the E2F2-deficient animals had entry in quiescent immortalized rat fibroblasts through survived to this age. To better ascertain the age-depenthe activation of target genes important at the G1/S dent abnormalities in the E2F2-deficient mice, four transition (Lukas et al., 1996 ; DeGregori et al., 1997).
E2F2-deficient and five wild-type littermates were sacriOther experiments have shown that E2F2 has oncogenic ficed at 15 months of age. Remarkably, all of the E2F2-activity (Wu and Levine, 1994) . Furthermore, E2F2 gene deficient mice, but none of the wild-type littermates, activity is induced during a proliferative response, leadexhibited features of marked autoimmune disease. ing to an accumulation of E2F2 coincident with S phase All of the aged E2F2-deficient mice displayed gross entry (Ikeda et al., 1996) . These results suggest that E2F2 splenomegaly, with spleen size two to five times higher may be necessary at the G1/S transition to promote cell than that in wild-type littermates. Spleen histology demcycle progression. However, recent studies indicate that onstrated white pulp hyperplasia and increased sinusoi-E2F2 can also trigger apoptosis under certain conditions dal cellularity ( Figure 2C ). Likewise, the livers of gests that E2F2 could play a unique role in vivo that is elderly E2F2-deficient mice exhibited numerous perinot shared by other members of the E2F family. vascular infiltrates ( Figure 2D ). The aged E2F2-deficient To assess the function of E2F2 in normal growth and mice also demonstrated evidence of skin abnormalities development and to test the role of E2F2 in the regulation consisting of considerable hair loss, skin wounds, and of proliferation, apoptosis, and/or differentiation in vivo, erythema affecting the head and neck region, reminiswe have inactivated the E2F2 locus in mice by homolocent of some autoimmune/inflammatory diseases (Figgous recombination. Mice lacking E2F2 are viable, yet ure 2F). The observed skin changes were not found in they exhibit defects in T lymphocyte homeostasis leadany of the wild-type control mice. ing to a lupus-like autoimmune disorder. E2F2-deficient Histology of the kidneys of elderly E2F2-deficient mice peripheral T lymphocytes exhibit enhanced proliferation demonstrated a membranoproliferative glomeruloneupon TCR-mediated stimulation, as well as a lower phritis that was focal and of moderate intensity. The threshold for activation. Thus, E2F2 functions in mice affected glomeruli were enlarged with a thickened baseas a negative regulator of the immune response by supment membrane and contained perivascular aggregates pressing cellular proliferation of activated lymphocytes. of inflammatory infiltrates. Immunocomplex deposition was detected in the affected areas, as determined by Results immunohistochemical analysis with antibodies to mouse IgG ( Figure 2E ). As shown, the E2F2-deficient kidneys Targeted Mutation of the E2F2 Gene in Mice contain prominent immune complex deposition, in sharp To study the function of E2F2, we generated mice deficontrast to the wild-type kidneys, which do not contain cient in E2F2 by gene targeting, using the strategy dethese complexes. picted in Figure 1 and Experimental Procedures. One
We also assayed serum from elderly wild-type and ES cell line produced high percentage chimeras and E2F2-deficient mice for the presence in the serum of was used to produce mice heterozygous for the E2F2 anti-dsDNA antibodies. Notably, the titer of IgG antibody mutation. Heterozygous mice carrying a null E2F2 allele against dsDNA observed in the E2F2-deficient mice corwere maintained in a mixed (C57Bl/6ϫ129/Sv) genetic related with the severity of the autoimmune organ dambackground in all experiments described here. The hetage observed in those mice and was significantly higher erozygotes appeared completely normal in their health than in wild-type controls (relative OD values for E2F2 . duced, again similar to wild-type ( Figure 3B ). Thus, we conclude that mutation of E2F2 does not impair thymic
The presence of a severe autoimmune syndrome in these mice, despite intact thymic negative selection, negative selection.
Although thymocyte development appeared normal points to a defect in peripheral mechanisms of selftolerance caused by the E2F2 mutation. Even with intact in E2F2-deficient Tg ϩ male mice, these mice became increasingly sick by 4 months of age and died by 5-7 thymic negative selection, a small number of self-reactive thymocytes normally escape negative selection months of age. By contrast, control E2F2 ϩ/ϩ Tg ϩ male mice remained healthy appearing to at least 12 months (Van Parijs and Abbas, 1998). Presumably, a failure of peripheral mechanisms of self-tolerance allows these of age. A detailed analysis of 5-month-old male mice revealed a number of features consistent with an inflamself-reactive lymphocytes to generate autoimmunity in the E2F2-deficient mice. The accelerated pace of autoof lymph nodes and spleen from anti-H-Y transgenic mice revealed a 2-to 3-fold increase in the proportion immunity when the E2F2 deficiency is in the background of the anti-H-Y transgene in male mice presumably reof H-Y-specific CD8 ϩ T cells in E2F2 mutant animals compared to wild-type controls, as detected by clonoflects the fact that in these mice most T cells that survive to the periphery express an anti-self TCR, specifically typic mAbs specific for the V␤8.2 chain and the V␣3 chain of the transgenic receptor ( Figures 3C and 3D 
). the anti-H-Y TCR (V␤8.2/V␣3).
Considering the fact that E2F2 Ϫ/Ϫ Tg ϩ male mice also develop marked splenomegaly, the absolute number of Expanded Memory T Cell Population potentially self-reactive peripheral T cells was dramatiDue to E2F2 Deficiency cally increased in the E2F2 Ϫ/Ϫ mice. We reasoned that the accelerated pace of autoimmunity
We measured the proliferation of these V␤8 ϩ /CD8 
anti-CD3 and measured the fraction of cells in S phase
lower than wild-type, whereas the fraction of apoptotic cells was increased ( Figures 5D and 5E ). Taken together, (determined by BrdU labeling index) and undergoing apoptosis (determined by TUNEL staining). As shown these results suggest that E2F1 and E2F2 play different roles in T lymphocyte function. in Figure 5E , the fraction of cells undergoing apoptosis was similar between wild-type and E2F2-deficient cells. By contrast, as shown in Figure 5D, 
lymphocytes were equally susceptible to cell death following anti-Fas or Dex treatment (data not shown). To test whether accumulation of T cells Impaired TCR-Stimulated Proliferation of E2F1-Deficient T Cells
with a memory phenotype in E2F2 Ϫ/Ϫ mice was due to a failure in activation-induced cell death, we stimulated The unexpected result that E2F2 Ϫ/Ϫ T lymphocytes exhibit increased proliferation prompted us to examine the T cells with Con A for 72 hr, followed by exposure to apoptotic stimuli, including anti-CD3, anti-Fas, serum, proliferation of E2F1-deficient T lymphocytes. Lymph node T cells from E2F1 Ϫ/Ϫ or wild-type mice were stimuand/or IL2 withdrawal. No significant differences between E2F2 ϩ/ϩ and E2F2 Ϫ/Ϫ cells were observed in apolated with antibodies against CD3, and DNA synthesis was measured 3 days after antigenic exposure. In conptotic responses to any of these treatments (Figure 6 ).
These results indicate that E2F2-deficient T cells show trast to the results with E2F2-deficient lymphocytes, E2F1-deficient T lymphocytes exhibited decreased antia normal sensitivity to apoptosis. CD3-stimulated proliferation compared to wild-type controls (Figure 5C). Thus, E2F1 gene deficiency results

Differential Gene Expression in E2F1 Ϫ/Ϫ and E2F2 Ϫ/Ϫ T Lymphocytes upon TCR Stimulation in impaired T cell responses, whereas E2F2 gene deficiency results in exaggerated T cell responses. In this
Serum stimulation has been found to induce the expression of E2F1 and E2F2 mRNA in fibroblasts at a time case, when we analyzed S phase entry and apoptosis of E2F1 Ϫ/Ϫ T cells, the fraction in S phase was significantly that coincides with the transition of cells from G1 into Figure 7A , in wildtype T lymphocytes both E2F1 and E2F2 mRNAs are distinct T cell responses that we found in E2F1 Ϫ/Ϫ and E2F2 Ϫ/Ϫ mice upon TCR-mediated activation prompted expressed after TCR stimulation but with differing kinetics; E2F1 mRNA levels peak 24 hr earlier than E2F2 us to examine the expression profiles of these genes in T lymphocytes obtained from wild-type, E2F1 Ϫ/Ϫ , and mRNA levels. As with fibroblasts, the timing of expression of E2F1 coincides with the transition into S phase, consistent with a role for E2F1 in the activation of the expression of genes required for DNA replication. By contrast, the delayed expression of E2F2 mRNA is not consistent with a role at the onset of S phase but instead might suggest a role in terminating the proliferative response. Interestingly, mutation of E2F1 affects the expression of E2F2, and vice versa. The expression of E2F2 mRNA is significantly reduced by mutation of E2F1, suggesting a role for E2F1 as a positive regulator of E2F2 expression, consistent with previous reports (Sears et al.,  1997) . Unexpectedly, mutation of E2F2 results in enhanced expression of E2F1, suggesting a negative regu- It has been demonstrated previously that E2F sites in the E2F1 promoter function to negatively regulate the die early due to autoimmune disease with features of splenomegaly, multiorgan inflammatory infiltrates, gloexpression of E2F1. The enhanced expression of E2F1 merulonephritis, and serum anti-DNA antibodies. E2F2-in the context of E2F2 deficiency suggests that E2F2 deficient T lymphocytes hyperproliferate in response to may at least partially mediate the repression of E2F1 in TCR stimulation, indicating that E2F2 functions as a T lymphocytes. We decided to directly test the ability negative regulator of cellular proliferation. Furthermore, of E2F2 to repress the E2F1 promoter in T cells. For this in striking contrast to E2F1, E2F2 can function in T lympurpose, we transfected asynchronously cycling Jurkat phocytes as a transcriptional repressor of genes con-T cells with an E2F1 promoter-luciferase reporter containing E2F sites, providing a mechanism for E2F2-medistruct either alone or with E2F1 or E2F2. As shown in ated suppression of cellular proliferation. Figure 7B , the promoter-reporter alone had significant Our investigation into the mechanism of autoimmunity basal activity. Cotransfection of an E2F1 expression in E2F2-deficient mice has revealed a number of surprisconstruct resulted in increased promoter activity, similar ing results. First, utilizing crosses with anti-H-Y transto previously published reports in other cell lines (Neugenic mice, we have been able to assess the requirement man et al., 1994). In striking contrast, cotransfection of for E2F2 for normal thymic negative selection, an important an E2F2 expression construct resulted in a significant mechanism for eliminating autoreactive T cells. We and and reproducible decrease in both basal promoter activothers have shown previously that E2F1 is required for ity and E2F1-stimulated E2F1 promoter activity. that rely upon E2F2 for Rb-mediated repression.
